{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

MSIF's 2006 Annual Review available soon

The 2006 MSIF Annual Review summarises the achievements of MSIF throughout 2006 and the impact these have had on our member societies, international MS research and people affected by MS worldwide.

read more

Guest speakers at MSIF meetings

MSIF is looking forward to welcoming guest speakers to the spring 2007 Board and Committee meetings, 18-20 April, in London.

read more

back to top

Profile of the Month : January 2008

Erlend Berntsen

Age: 27
Country: Norway
Occupation: Admissions Officer
Year of diagnosis: 2000

"I’ve tried to maintain my hopes and dreams for the future."

English Italiano Espanol Deutsch Francais Russian

read more

back to top

The neuropsychiatry of multiple sclerosis: a review of recent developments

The authors reviewed the most recent developments on cognitive and psychiatric symptoms in people with MS.

authors: Ghaffar O, Feinstein A.

source: Curr Opin Psychiatry. 2007 May;20(3):278-85

read more

Progression in multiple sclerosis: Further evidence of an age dependent process

This study gives further support to the notion that the older people are at the onset of MS the shorter the time to progression, independent of the number of relapses.

authors: Koch M, Mostert J, Heersema D, De Keyser J.

source: J Neurol Sci. 2007 Apr 15;255(1-2):35-41

read more

N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry

The authors looked for N-acetylaspartic acid, a neuron specific marker, in the cerebrospinal fluid of people with different subtypes of MS. They found correlations with clinical disability and with imaging measures of lesion load. They concluded that it is therefore an important marker of disease severity.

authors: Jasperse B, Jakobs C, Eikelenboom MJ, Dijkstra CD, Uitdehaag BM, Barkhof F, Polman CH, Teunissen CE.

source: J Neurol. 2007 Apr 6

read more

Origin of Fatigue in Multiple Sclerosis: Review of the Literature

The authors reviewed the different causes contributing to fatigue, one of the most common symptoms in MS.

authors: Kos D, Kerckhofs E, Nagels G, D'hooghe MB, Ilsbroukx S.

source: Neurorehabil Neural Repair. 2007 Apr 4

read more

back to top

The Ethics of Placebo Controls in MS Clinical Trials: International Meeting Convened by US National MS Society

source: US National MS Society

An international panel met in Washington, DC, recently under the auspices of the US National MS Society’s International Advisory Committee on Clinical Trials in MS to discuss the ethics of conducting placebo-controlled trials in multiple sclerosis.

read more

MS Ireland's National Convention 2007

source: MS Ireland

MSLiving will be the biggest event ever held in Ireland for people living with or interested in multiple sclerosis. The one day convention will cover every aspect of MS through exhibitions, talks and debate.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.